|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn952709689 |
003 |
OCoLC |
005 |
20231120112119.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
160701s2016 enk ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d YDX
|d OCLCA
|d U3W
|d D6H
|d WYU
|d UWO
|d VLY
|d S2H
|d OCLCO
|d REDDC
|d UX1
|d VT2
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 1066522234
|a 1162601808
|a 1229063883
|a 1229133218
|a 1235116899
|a 1235842622
|a 1257384251
|a 1259584088
|
020 |
|
|
|a 0128039795
|
020 |
|
|
|a 9780128039793
|
020 |
|
|
|a 0128039523
|
020 |
|
|
|a 9780128039526
|
020 |
|
|
|z 9780128039526
|q (print)
|
035 |
|
|
|a (OCoLC)952709689
|z (OCoLC)1066522234
|z (OCoLC)1162601808
|z (OCoLC)1229063883
|z (OCoLC)1229133218
|z (OCoLC)1235116899
|z (OCoLC)1235842622
|z (OCoLC)1257384251
|z (OCoLC)1259584088
|
050 |
|
4 |
|a RA1247.M8
|
060 |
|
4 |
|a WF 600
|
082 |
0 |
4 |
|a 615.9/1
|2 23
|
100 |
1 |
|
|a Ghanei, Mostafa,
|e author.
|
245 |
1 |
0 |
|a Mustard lung :
|b diagnosis and treatment of respiratory disorders in sulfur-mustard injured patients /
|c Mostafa Ghanei, Ali Amini Harandi.
|
264 |
|
1 |
|a London, UK :
|b Academic Press is an imprint of Elsevier,
|c 2016.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Mustard Lung: Diagnosis and Treatment of Respiratory Disorders in Sulfur-Mustard Injured Patients brings together the details regarding pathophysiology, medication, and protective issues to provide a comprehensive look at health problems associated with sulfur mustard injury. It provides a bench-to-bedside look at the long term complications of vesicant exposure in humans as well as how mustard gas exposure affects lung function. By providing guidelines and approaches for the diagnosis, pathogenesis, and treatment of SM injury cases, this book is helpful for a wide range of medical researchers and clinicians. For decades, chemical respiratory disorders were diagnosed and managed traditionally similar to other chronic respiratory diseases. However, the exact nature of chemical respiratory disorders is different and needs to be treated as such.
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed July 1, 2016).
|
505 |
0 |
|
|a Front Cover; Mustard Lung; Mustard Lung: Diagnosis and Treatment of Respiratory Disorders in Sulfur Mustard-Injured Patients; Copyright; Contents; Preface; 1 -- History of Chemical Weapons Use; REFERENCES; 2 -- Classification of Chemical Warfare Agents and Properties of Sulfur Mustard; DEFINITION AND CLASSIFICATION OF CHEMICAL WARFARE AGENTS; PHYSICAL AND CHEMICAL PROPERTIES OF SULFUR MUSTARD; REFERENCES; 3 -- Biochemical and Cellular-Molecular Mechanisms of Injury From Mustard Gas; THE MECHANISM OF INJURY IN THE ACUTE PHASE; PATHOPHYSIOLOGY OF MUSTARD GAS INJURY; INFLAMMATION; OXIDATIVE STRESS.
|
505 |
8 |
|
|a APOPTOSISINCREASED PROTEOLYTIC ACTIVITY; DNA Damage; ROLE OF IMMUNE CELLS IN CHEMICALLY INJURED PATIENTS; GRANULOCYTES; MONOCYTES AND MACROPHAGES; T CELLS; CHANGES IN ANTIBODIES; REFERENCES; 4 -- The Effects of Mustard Gas on Pulmonary Function and Structure; LONG-TERM CLINICAL AND HISTOLOGICAL EVALUATION OF INDIVIDUALS EXPOSED TO MUSTARD GAS; CHANGES OF THE RESPIRATORY TRACTS DUE TO MUSTARD GAS; UPPER RESPIRATORY TRACT; TRACHEOBRONCHOMALACIA AND AIR TRAPPING FOLLOWING EXPOSURE TO MUSTARD GAS; BASICS OF PULMONARY FUNCTION TESTS; GAS EXCHANGE CAPACITY OF THE LUNG; BRONCHIAL CHALLENGE TESTING.
|
505 |
8 |
|
|a CARDIOPULMONARY EXERCISE TESTINGPOLYSOMNOGRAPHY; PULMONARY GAS EXCHANGE; RESULTS OF PULMONARY FUNCTION TESTING IN CHEMICAL PATIENTS; PULMONARY FUNCTION TESTING IN SUBCLINICAL CONTACT WITH MUSTARD GAS; PULMONARY FUNCTION TESTING IN SYMPTOMATIC CHEMICAL PATIENTS; EVALUATION OF THE RELATIONSHIP BETWEEN FATIGUE AND SPIROMETRIC PARAMETERS IN CHEMICAL PATIENTS WITH RESPIRATORY DISORDERS; CARDIOPULMONARY EXERCISE TESTING IN SYMPTOMATIC CHEMICAL PATIENTS; REFERENCES; 5 -- Signs and Symptoms of Exposure to Mustard Gas; SYMPTOMS OF THE ACUTE PHASE; LATE SYMPTOMS OF EXPOSURE TO MUSTARD GAS; UPPER AIRWAYS.
|
505 |
8 |
|
|a LOWER AIRWAYSCHRONIC COUGH; PREVALENCE AND DIAGNOSIS OF EMPHYSEMA IN CHEMICAL PATIENTS; CARCINOGENIC PROPERTIES OF MUSTARD GAS; OTHER INJURIES OF PULMONARY AIRWAYS AND PARENCHYMA; ACCUMULATION OF SECRETIONS IN THE AIRWAYS; IMPAIRMENT OF VENTILATION AND PERFUSION; AIRWAYS BLEEDING (HEMOPTYSIS); BIOCHEMICAL ABNORMALITIES OF THE LUNG; PULMONARY VASCULAR INJURY; IMPAIRMENT OF PULMONARY IMMUNE CELLS; SIGNS AND SYMPTOMS OF OCULAR LESIONS; SIGNS AND SYMPTOMS OF SKIN LESIONS; NONSPECIFIC SYMPTOMS OF MUSTARD GAS; REFERENCES; 6 -- Gastroesophageal Reflux in Chemical Patients.
|
505 |
8 |
|
|a CHRONIC PULMONARY DISEASE AND GASTROESOPHAGEAL REFLUXMECHANISMS INVOLVED IN THE PATHOGENESIS OF REFLUX AND PULMONARY DISEASES; GASTROESOPHAGEAL REFLUX IN CHEMICAL PATIENTS; CONCLUSIONS; REFERENCES; 7 -- Diagnostic Methods in Chemical Patients; Laboratory Findings; URINE SAMPLE; BLOOD SAMPLES; OTHER SAMPLES; PARACLINICAL FINDINGS; RADIOLOGY; CHEST X-RAY; Chest X-ray Findings in Asymptomatic Patients; Chest X-ray Findings in Symptomatic Patients; PULMONARY PERFUSION SCAN; PULMONARY CT SCAN; LUNG HRCT IN ASYMPTOMATIC PATIENTS; HRCT IN SYMPTOMATIC PATIENTS; AIRWAY STENOSIS IN PULMONARY SCAN.
|
504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
650 |
|
0 |
|a Mustard gas
|x Physiological effect.
|
650 |
|
0 |
|a Mustard gas
|x Health aspects.
|
650 |
|
0 |
|a War wounds.
|
650 |
1 |
2 |
|a Mustard Gas
|x adverse effects
|0 (DNLM)D009151Q000009
|
650 |
1 |
2 |
|a Lung Injury
|x diagnosis
|0 (DNLM)D055370Q000175
|
650 |
2 |
2 |
|a Lung Injury
|x therapy
|0 (DNLM)D055370Q000628
|
650 |
|
6 |
|a Gaz moutarde
|0 (CaQQLa)201-0152488
|x Effets physiologiques.
|0 (CaQQLa)201-0374337
|
650 |
|
6 |
|a Blessures de guerre.
|0 (CaQQLa)201-0228464
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Lungs
|x Diseases.
|2 fast
|0 (OCoLC)fst01003777
|
700 |
1 |
|
|a Harandi, Ali Amini,
|e author.
|
776 |
0 |
|
|z 0128039523
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128039526
|z Texto completo
|